P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: Results of a 6-year prospective study

British Journal of Haematology

Volumn 105, Issue 3, 1999, Pages 676-683

  Dhooge, Catharina ^a   De Moerloose, B ^a   Laureys, G ^a   Kint, J ^a   Ferster, A ^b   De Bacquer, D ^a   Philippe, J ^a   Benoit, Y ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Dept of Paediatr 'Reine Fabiola' ^*  (Belgium)

Author keywords

Childhood ALL; Immunocytochemistry; MDR; P glycoprotein

Indexed keywords

GLYCOPROTEIN P;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOCYTOCHEMISTRY; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; REMISSION; RISK ASSESSMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; P-GLYCOPROTEIN; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 0033040149     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01378.x     Document Type: Article

References (26)

1. Baines, P., Cumber, R & Padua, R.A. (1992) Multidrug resistance in leukaemia. Baillieres Clinical Haematology, 5, 943-960.
2. Beck, W.T., Grogan. T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Bates, S.E., Berard, C.W., Boyet, J.M., Brophy, N.A., Broxterman, H.J.. Chan, H.S.L., Dalton, W.S., Dietel, M., Fojo, A.T., Gascoyne, R.D., Head, D., Houghton, P.J., Srivastava, D.K., Lehnert, M., Leith, C.P., Paietta, E., Pavelic, Z.P., Rimsza, L., Roninson, I.B., Sikic, B.I., Twentyman, P.R., Warnke, R. & Weinstein, R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Research, 56, 3010-3020.
3. Chan, H.S.L., Thorner, P.S., Haddad, G., Deboer, G., Gallie, B. & Ling, V. (1995) Multidrug resistance in malignancies of children. International Journal of Pediatric Hematology/Oncology, 2, 11-29.
4. Cordell, J.L., Falini, B. & Erber, W.N. (1984) Immunoenzymatic labeling of monoclonal antibodies using immunecomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. Journal of Histochemistry and Cytochemistry, 32, 219-229.
5. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S., & Papa, G. (1996) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1007-2004.
6. den Boer, M.L., Pieters, R., Kazemier, K.M., Rottier, M.M.A., Zwaan, C.M., Kaspers, G.J.L., Janka-Schaub, G., Henze, G., Creutzig, U., Scheper, R.J. & Veerman, A.J.P. (1998) Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression and drug resistance in childhood leukemia. Blood, 91, 2092-2098.
7. den Boer, M.L., Zwaan, C.M., Pieters, R., Kazemier, K.M., Rottier, M.M.A., Flens, M.J., Scheper, R.J. & Veerman, A.J.P. (1997) Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia, 11, 1078-1085.
8. De Moerloose, B., Dhooge, C. & Philippé, J. (1998) Discordance of P-glycoprotein expression and function in acute leukemia. Advances in Experimental Medicine and Biology (proceedings of the third international symposium : drug resistance in leukemia and lymphoma), in press.
9. Dhooge, C., De Moerloose, B., De Potter, C., Laureys, G., Benoit, Y. & Leroy, J. (1994) Expression of the multidrug transporter. P-glycoprotein, in childhood leukemia: a prospective clinical study. International Journal of Pediatric Hematology/Oncology, 1, 311-314.
10. Filipits, M., Suchomel, R.W., Lechner, K. & Pirker, R. (1997) Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status. Leukemia, 11, 1073-1077.
11. Gala, J.L., McLachlan, J.M., Bell, D.R., Michaux, J.L. & Ma, D.D.F. (1994) Specificity and sensitivity of immunocytochemistry for detecting P-glycoprotein in haematological malignancies. Journal of Clinical Pathology, 47, 619-624.
12. Goasguen, J.E., Dossot, J.-M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P., Chaperon, J. & Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-GP) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394-2398.
13. Harrison, D.J. (1995) Molecular mechanisms of drug resistance in tumours. Journal of Pathology, 175, 7-12.
14. Ivy, S.P., Olshefski, R.S., Taylor, B.J., Patel, K.M. & Reaman, G.H. (1996) Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children's Cancer Group Study. Blood, 88, 309-318.
15. Kartner, N. & Ling, V. (1989) Multidrug resistance in cancer. Scientific American, 260, (March), 44-51.
16. Knaust, E., MacDonald, P. & Gruber, A. (1998) Heterogeneity in blast cell populations in acute myeloid leukemia (AML) affects accumulation and efflux of daunorubicin. (Abstract). Leukemia, 12, 272.
17. Langermann, H.J. Henze, G., Wulf, M. & Riehm, H. (1982) Abschatzung der Tumorzellmasse bei der akuten lymphoblastischen Leukamie im Kindersalter: prognostische Bedeutung und praktische Anwendung. Klinische Pediatrie, 194, 209-213.
18. Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.-M., Head, D.R., Appelbaum, F.R. & Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood, 89, 3323-3329.
19. List, A.F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M. & Dalton, W. (1993) Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. Journal of Clinical Oncology, 11, 1652-1660.
20. Marie, J.-P. (1995) P-glycoprotein in adult hematologic malignancies. Hematological/Oncological Clinics of North America, 9, 239-248.
21. Marie, J.-P. (1997) Multicentric evaluation of the MDR phenotype in leukemia. Leukemia, 11, 1086-1094.
22. Pui, C.-H. (1995) Childhood leukemias. New England Journal of Medicine, 332, 1618-1630.
23. Sonneveld, P., Durie, B.G.M. & Lokhorst, H.M. (1992) Modulation of multidrug resistance by cyclosporine. Lancet, 340, 255-259.
24. Sonneveld, P., Lowenberg, B., Vossebeld, P., Malkhandi, J., Covelli, A. & Burnett, A. (1998) Modulation of P-gp mediated MDR in leukemia. (Abstract). Leukemia, 12, 256.
25. Van den Heuvel-Eibrinck, M.M.., van der Holt, B., Te Boekhorst, P.A.W., Pieters, R., Schoester, M., Lowenberg, B. & Sonneveld, P. (1997) MDR1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia. British Journal of Haematology, 99, 76-83.
26. van der Heyden, S., Gheuens, E., De Bruijn, E., Van Oosterom, A. & Maes, R. (1995) P-glycoprotein: clinical significance and methods of analysis. Critical Reviews in Clinical Laboratory Sciences, 32, 221-264.